AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Recommendation of “Moderate Buy” from Brokerages

by · The Markets Daily

AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) has received a consensus rating of “Moderate Buy” from the six analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $11.67.

Several equities analysts recently issued reports on the stock. Truist Financial dropped their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 15th. Canaccord Genuity Group dropped their price objective on AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. UBS Group decreased their target price on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Royal Bank of Canada dropped their price target on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. Finally, Robert W. Baird cut their price target on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th.

Get Our Latest Report on AHCO

AdaptHealth Price Performance

AdaptHealth stock opened at $9.36 on Thursday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The stock has a market capitalization of $1.26 billion, a P/E ratio of -5.67, a price-to-earnings-growth ratio of 1.36 and a beta of 1.10. AdaptHealth has a 52 week low of $6.46 and a 52 week high of $11.90. The stock has a fifty day moving average of $10.04 and a 200-day moving average of $10.41.

AdaptHealth (NASDAQ:AHCO – Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The firm had revenue of $805.90 million for the quarter, compared to the consensus estimate of $809.32 million. During the same quarter in the prior year, the firm earned $0.19 EPS. The company’s revenue was up .2% on a year-over-year basis. On average, sell-side analysts expect that AdaptHealth will post 0.88 earnings per share for the current fiscal year.

Institutional Investors Weigh In On AdaptHealth

Several institutional investors and hedge funds have recently modified their holdings of AHCO. FMR LLC grew its position in AdaptHealth by 9.3% during the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock valued at $82,547,000 after purchasing an additional 624,645 shares during the last quarter. Reinhart Partners LLC. grew its holdings in shares of AdaptHealth by 45.2% in the third quarter. Reinhart Partners LLC. now owns 6,198,642 shares of the company’s stock worth $69,611,000 after acquiring an additional 1,929,339 shares during the period. State Street Corp increased its position in AdaptHealth by 19.8% during the third quarter. State Street Corp now owns 4,124,284 shares of the company’s stock valued at $46,316,000 after acquiring an additional 681,816 shares during the last quarter. Segall Bryant & Hamill LLC lifted its holdings in AdaptHealth by 15.5% in the third quarter. Segall Bryant & Hamill LLC now owns 3,701,808 shares of the company’s stock valued at $41,571,000 after acquiring an additional 496,453 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in AdaptHealth by 12.2% in the third quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company’s stock valued at $27,532,000 after acquiring an additional 265,712 shares during the period. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Company Profile

(Get Free Report

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Read More